Erhalte mehr Antworten von Arbeitgebern
Versende in nur wenigen Minuten einen passgenauen Lebenslauf.
OM Pharma, a Geneva-based biopharmaceutical leader, seeks a Safety & Environment Engineer for its Meyrin site. You will lead the Safety & Environment strategy, ensuring regulatory compliance and a strong safety culture.
The role combines hands-on operations with strategic leadership across cross-functional teams. Requirements include a Bachelor's or Master's in a related field, CFST Safety Officer/Engineer certification, and 3–5 years of experience in SHE management within manufacturing.
We are currently recruiting a Safety & Environment Engineer based at our global headquarters and biotech production site in Meyrin. Reporting directly to the Head of Engineering & Technical Projects and working closely with cross-functional teams, your mission is to lead and continuously improve the site's Safety & Environment programs. This role combines hands-on operational activities and strategic leadership.
To carry out this mission, we are looking for a candidate with the following profile:
You are a proactive and collaborative professional with strong communication and interpersonal skills. With a strong hands-on approach and visible field presence, you build trust and engage stakeholders, balancing firmness and diplomacy to drive accountability and sustainable change. Pragmatic and solution-oriented, you combine operational rigor with a continuous improvement mindset. Committed to workplace safety and environmental protection, you lead by example and contribute to a culture of excellence.
If you are looking for a role where you can make a real impact on employee safety, environmental performance, and operational excellence, we would love to hear from you.
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases.
It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections.
The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.
For more information, visit the website: ompharma.com.